Cargando…

Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720

Adjuvants are essential for vaccine development, especially subunit-based vaccines such as those containing recombinant proteins. Increasing the knowledge of the immune response mechanisms generated by adjuvants should facilitate the formulation of vaccines in the future. The present work describes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Rodolfo F., de Melo, Filipe Menegatti, Novais, Janaina Tenório, Soares, Irene S., Bargieri, Daniel Youssef, Gimenez, Alba Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278660/ https://www.ncbi.nlm.nih.gov/pubmed/35844531 http://dx.doi.org/10.3389/fimmu.2022.910022

Ejemplares similares

Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
por: Ascarateil, Stephane, et al.
Publicado: (2015)

Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
por: Ascarateil, Stephane, et al.
Publicado: (2015)

Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG
por: van Loon, Karlijn, et al.
Publicado: (2022)

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
por: Roestenberg, Meta, et al.
Publicado: (2008)

Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum
por: Pal, Sukumar, et al.
Publicado: (2023)

Modulation of Antibody Responses against Gnathostoma spinigerum in Mice Immunized with Crude Antigen Formulated in CpG Oligonucleotide and Montanide ISA720
por: Intapan, Pewpan M., et al.
Publicado: (2013)

Evaluation of Montanide™ ISA 71 VG Adjuvant during Profilin Vaccination against Experimental Coccidiosis
por: Jang, Seung I., et al.
Publicado: (2013)

Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
por: Hu, Jinhong, et al.
Publicado: (2008)

A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis
por: Ricciardi, Alessandra, et al.
Publicado: (2016)

Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen
por: Thim, Hanna L., et al.
Publicado: (2014)

A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
por: McCarthy, James S., et al.
Publicado: (2011)

LigA formulated in AS04 or Montanide ISA720VG induced superior immune response compared to alum, which correlated to protective efficacy in a hamster model of leptospirosis
por: Varma, Vivek P., et al.
Publicado: (2022)

A novel bivalent Pasteurellosis-RHD vaccine candidate adjuvanted with Montanide ISA70 protects rabbits from lethal challenge
por: El-Jakee, Jakeen K., et al.
Publicado: (2020)

Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants
por: Rathogwa, Ntungufhadzeni M., et al.
Publicado: (2021)

Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis
por: Şahar, Esra Atalay, et al.
Publicado: (2020)

Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies
por: Zahmati, Sara, et al.
Publicado: (2021)

Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity
por: Graham, Barney S., et al.
Publicado: (2010)

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
por: Wu, Yimin, et al.
Publicado: (2008)

Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses
por: Savoji, Mohammad Ali, et al.
Publicado: (2019)

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
por: Kuball, Jürgen, et al.
Publicado: (2010)

Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Diagnostic Methods for Non-Falciparum Malaria
por: Gimenez, Alba Marina, et al.
Publicado: (2021)

A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
por: Motavalli Khiavi, Farhad, et al.
Publicado: (2018)

Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope
por: Wilson, Kirsty L., et al.
Publicado: (2015)

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019)

Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
por: Ibrahim, Ehab El-Sayed, et al.
Publicado: (2015)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021)

linkedISA: semantic representation of ISA-Tab experimental metadata
por: González-Beltrán, Alejandra, et al.
Publicado: (2014)

ISA system architecture /
por: Shanley, Tom
Publicado: (1995)

Poly I:C causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund's complete adjuvant
por: De Alba, Jorge, et al.
Publicado: (2013)

Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide(TM) Pet Gel in murine model
por: MATHEW, Manu Kurian, et al.
Publicado: (2019)

mzML2ISA & nmrML2ISA: generating enriched ISA-Tab metadata files from metabolomics XML data
por: Larralde, Martin, et al.
Publicado: (2017)

isa4j: a scalable Java library for creating ISA-Tab metadata
por: Psaroudakis, Dennis, et al.
Publicado: (2020)

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs
por: Thomas, Milton, et al.
Publicado: (2015)

Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022)

ISA Server 2004 unleashed
por: Noel, Michael
Publicado: (2006)

Message by President ISA-National
por: Venkatagiri, K. M.
Publicado: (2022)

Message by Secretary ISA National
Publicado: (2022)

Message by the President ISA National
por: Venkatagiri, K.M
Publicado: (2022)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nbk2l6p8f09ki8jnbarha6tml5